Research workbench
Structure of salmonella enterica effector protein ssel
Analyse Structure of salmonella enterica effector protein ssel in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 5HAF
- Type
- protein
- Length
- 639 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Deubiquitinase ssel
- EC
- 3.4.22.-
- UniProt
- Q8ZNG2
- Ligands
- K
- Pockets
- 8 · best druggability 0.74
Structure
x-ray diffraction · 2 distinct chains · 52% helix, 11% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Deubiquitinase ssel (EC 3.4.22.-) | protein | 312 | 55% helix, 11% strand | Q8ZNG2 |
| B | Deubiquitinase ssel (EC 3.4.22.-) | protein | 327 | 49% helix, 11% strand | Q8ZNG2 |
Ligands and binding sites
- K · Potassium ion · metal · 3 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 300 | 0.74 | 0.86 | 43 | K |
| 2 | 429 | 0.70 | 0.81 | 43 | empty |
| 3 | 343 | 0.56 | 0.75 | 49 | empty |
| 4 | 156 | 0.43 | 0.75 | 27 | empty |
| 5 | 50 | 0.34 | 0.79 | 14 | empty |
Interfaces
1 interface between chains.
- A–B · 1243 Ų buried · 19 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8ZNG2
- Elsewhere: RCSB PDB 5HAF · PDBe 5HAF · UniProt Q8ZNG2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.